Pfizer Canada ULC reported 2 lobbying communications with federal officials between Jul 16, 2026 and Jul 29, 2026.
Officials contacted: Julie Harb (Policy Advisor); Kody Blois (Member of Parliament).
On the agenda: Advocacy as it relates to the Government of Canada potential responses to the US Administration Most Favored Nation drug pricing policy; Advocacy related to the federal government consultation on the review of the Canada US Mexico Trade Agreement; Advocacy related to the new Buy Canada policy and the implications of including goods and services related to healthcare delivery, medical treatment, in particular drugs, vaccines and biologicals.
